Terlipressin Shows Benefit in Hepatorenal Syndrome Terlipressin Shows Benefit in Hepatorenal Syndrome
Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome, although not without potentially serious side effects.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Nephrology News Source Type: news
More News: Surgery | Urology & Nephrology